Pharmaceutical news

Even after rising 17% this past week, Fusen Pharmaceutical (HKG:1652) shareholders are still down 72% over the past three years - Simply Wall St

External page is loading, the page should display in a few seconds..

    Follow @Pharma_NewsUS on Twitter!